Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats

M Carta, T Carlsson, D Kirik, A Björklund - Brain, 2007 - academic.oup.com
In patients with Parkinson's disease, the therapeutic efficacy of l-DOPA medication is
gradually lost over time, and abnormal involuntary movements, dyskinesias, gradually …
被引用次数：720 相关文章

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

M Carta, T Carlsson, D Kirik, A Björklund - Brain, 2007 - portal.research.lu.se
Abstract n patients with Parkinson's disease, the therapeutic efficacy of L-DOPA medication
is gradually lost over time, and abnormal involuntary movements, dyskinesias, gradually …

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

M Carta, T Carlsson, D Kirik, A Björklund - Brain, 2007 - lup.lub.lu.se
n patients with Parkinson's disease, the therapeutic efficacy of L-DOPA medication is
gradually lost over time, and abnormal involuntary movements, dyskinesias, gradually …

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

M Carta, T Carlsson, D Kirik… - Brain: a journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
In patients with Parkinson's disease, the therapeutic efficacy of L-DOPA medication is
gradually lost over time, and abnormal involuntary movements, dyskinesias, gradually …

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

M Carta, T Carlsson, D Kirik, A Bjorklund - Brain, 2007 - elibrary.ru
In patients with Parkinsons disease, the therapeutic efficacy of l-DOPA medication is
gradually lost over time, and abnormal involuntary movements, dyskinesias, gradually …

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

M Carta, T Carlsson, D Kirik… - Brain: a Journal of …, 2007 - europepmc.org
In patients with Parkinson's disease, the therapeutic efficacy of L-DOPA medication is
gradually lost over time, and abnormal involuntary movements, dyskinesias, gradually …

[引用][C] Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

M CARTA, T CARLSSON, D KIRIK, A BJÖRKLUND - Brain, 2007 - pascal-francis.inist.fr
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in
parkinsonian rats CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

M CARTA, T CARLSSON - BRAIN, 2007 - iris.unica.it
In patients with Parkinson's disease, the therapeutic efficacy of L-DOPA medication is
gradually lost over time, and abnormal involuntary movements, dyskinesias, gradually …

[引用][C] Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

M Carta, T Carlsson, D Kirik, A Bjorklund - Brain, 2007 - cir.nii.ac.jp
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in
parkinsonian rats | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

[引用][C] Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

M CARTA - Brain, 2007 - cir.nii.ac.jp
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in
parkinsonian rats | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …